Oskari Kulta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Oskari Kulta has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Susanna Narkilahti
NeuroGroup, Faculty of Medicine and Health Technology Tampere University Tampere Finland
5 shared publications - Lotta Isosaari
NeuroGroup, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
4 shared publications - Andrey Vinogradov
NeuroGroup, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
2 shared publications Fikret Emre Kapucu
NeuroGroup, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
2 shared publicationsValtteri Vuolanto
NeuroGroup, Faculty of Medicine and Health Technology Tampere University Tampere Finland
2 shared publicationsAndrey Vinogradov
NeuroGroup, Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland
1 shared publication
Latest Publications
- Open Access
- 23 November 2025
- Published by Elsevier in Neuroscience
- Vol. 592, 83-96
In vitro identification of kainic acid-induced, concentration-dependent responses in human cortical neuronal networks
- 23 November 2025
- Published by Elsevier in Neuroscience
- Vol. 592, 83-96
Open AccessIn vitro identification of kainic acid-induced, concentration-dependent responses in human cortical neuronal networks
- Open Access
- 22 September 2025
- Published by Elsevier in Neuroscience Research
- Vol. 220, 104958
Abnormalities in the functional activity of neural networks in a human iPSC model of Dravet syndrome
- 22 September 2025
- Published by Elsevier in Neuroscience Research
- Vol. 220, 104958
Open AccessAbnormalities in the functional activity of neural networks in a human iPSC model of Dravet syndrome
- Open Access
- 25 April 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (8) , e70567
Functional 3D Human Neuron–Glioblastoma Model Reveals Cellular Interactions Enabling Drug Safety Assessments
Glioblastoma (GB) cells actively interact with the central nervous system (CNS) tumor microenvironment (TME). These interactions, particularly with neurons, require a better understanding. 3D tumor models replicating the human TME are needed to unravel pathological processes and to test novel treatments for efficacy and safety. We developed a novel 3D human coculture model for studying neuron–GB interactions. The model revealed both structural and functional interactions between cell types. Paracrine communication in the coculture model favored a tumor‐supportive environment. Notably, cell‐specific calcium signaling characteristics differed in cocultures compared to monocultures, highlighting the impact of interactions on cellular functionality in TME. The safety of a clinically used treatment, temozolomide, was tested in the 3D coculture model, and it selectively inhibited GB invasion while preserving neurons' morphology and functionality. The established model provides a tool for dissecting the interactions within the TME and testing the efficacy and safety of novel treatments.
- 25 April 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (8) , e70567
Open AccessFunctional 3D Human Neuron–Glioblastoma Model Reveals Cellular Interactions Enabling Drug Safety Assessments
Glioblastoma (GB) cells actively interact with the central nervous system (CNS) tumor microenvironment (TME). These interactions, particularly with neurons, require a better understanding. 3D tumor models replicating the human TME are needed to unravel pathological processes and to test novel treatments for efficacy and safety. We developed a novel 3D human coculture model for studying neuron–GB interactions. The model revealed both structural and functional interactions between cell types. Paracrine communication in the coculture model favored a tumor‐supportive environment. Notably, cell‐specific calcium signaling characteristics differed in cocultures compared to monocultures, highlighting the impact of interactions on cellular functionality in TME. The safety of a clinically used treatment, temozolomide, was tested in the 3D coculture model, and it selectively inhibited GB invasion while preserving neurons' morphology and functionality. The established model provides a tool for dissecting the interactions within the TME and testing the efficacy and safety of novel treatments.
- Open Access
- 6 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402504
Hyaluronic Acid‐Based 3D Bioprinted Hydrogel Structure for Directed Axonal Guidance and Modeling Innervation In Vitro
Neurons form predefined connections and innervate target tissues through elongating axons, which are crucial for the development, maturation, and function of these tissues. However, innervation is often overlooked in tissue engineering (TE) applications. Here, multimaterial 3D bioprinting is used to develop a novel 3D axonal guidance structure in vitro. The approach uses the stiffness difference of acellular hyaluronic acid‐based bioink printed as two alternating, parallel‐aligned filaments. The structure has soft passages incorporated with guidance cues for axonal elongation while the stiff bioink acts as a structural support and contact guidance. The mechanical properties and viscosity differences of the bioinks are confirmed. Additionally, human pluripotent stem cell (hPSC) ‐derived neurons form a 3D neuronal network in the softer bioink supplemented with guidance cues whereas the stiffer restricts the network formation. Successful 3D multimaterial bioprinting of the axonal structure enables complete innervation by peripheral neurons via soft passages within 14 days of culture. This model provides a novel, stable, and long‐term platform for studies of 3D innervation and axonal dynamics in health and disease.
- 6 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (1) , e2402504
Open AccessHyaluronic Acid‐Based 3D Bioprinted Hydrogel Structure for Directed Axonal Guidance and Modeling Innervation In Vitro
Neurons form predefined connections and innervate target tissues through elongating axons, which are crucial for the development, maturation, and function of these tissues. However, innervation is often overlooked in tissue engineering (TE) applications. Here, multimaterial 3D bioprinting is used to develop a novel 3D axonal guidance structure in vitro. The approach uses the stiffness difference of acellular hyaluronic acid‐based bioink printed as two alternating, parallel‐aligned filaments. The structure has soft passages incorporated with guidance cues for axonal elongation while the stiff bioink acts as a structural support and contact guidance. The mechanical properties and viscosity differences of the bioinks are confirmed. Additionally, human pluripotent stem cell (hPSC) ‐derived neurons form a 3D neuronal network in the softer bioink supplemented with guidance cues whereas the stiffer restricts the network formation. Successful 3D multimaterial bioprinting of the axonal structure enables complete innervation by peripheral neurons via soft passages within 14 days of culture. This model provides a novel, stable, and long‐term platform for studies of 3D innervation and axonal dynamics in health and disease.
- Open Access
- 28 July 2024
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-20
Human tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson’s Disease
Previous studies have shown that aggregated alpha-synuclein (α-s) protein, a key pathological marker of Parkinson’s disease (PD), can propagate between cells, thus participating in disease progression. This prion-like propagation has been widely studied using in vivo and in vitro models, including rodent and human cell cultures. In this study, our focus was on temporal assessment of functional changes during α-s aggregation and propagation in human induced pluripotent stem cell (hiPSC)-derived neuronal cultures and in engineered networks. Here, we report an engineered circular tripartite human neuronal network model in a microfluidic chip integrated with microelectrode arrays (MEAs) as a platform to study functional markers during α-s aggregation and propagation. We observed progressive aggregation of α-s in conventional neuronal cultures and in the exposed (proximal) compartments of circular tripartite networks following exposure to preformed α-s fibrils (PFF). Furthermore, aggregated forms propagated to distal compartments of the circular tripartite networks through axonal transport. We observed impacts of α-s aggregation on both the structure and function of neuronal cells, such as in presynaptic proteins, mitochondrial motility, calcium oscillations and neuronal activity. The model enabled an assessment of the early, middle, and late phases of α-s aggregation and its propagation during a 13-day follow-up period. While our temporal analysis suggested a complex interplay of structural and functional changes during the in vitro propagation of α-s aggregates, further investigation is required to elucidate the underlying mechanisms. Taken together, this study demonstrates the technical potential of our introduced model for conducting in-depth analyses for revealing such mechanisms.
- 28 July 2024
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 10 (1) , 1-20
Open AccessHuman tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson’s Disease
Previous studies have shown that aggregated alpha-synuclein (α-s) protein, a key pathological marker of Parkinson’s disease (PD), can propagate between cells, thus participating in disease progression. This prion-like propagation has been widely studied using in vivo and in vitro models, including rodent and human cell cultures. In this study, our focus was on temporal assessment of functional changes during α-s aggregation and propagation in human induced pluripotent stem cell (hiPSC)-derived neuronal cultures and in engineered networks. Here, we report an engineered circular tripartite human neuronal network model in a microfluidic chip integrated with microelectrode arrays (MEAs) as a platform to study functional markers during α-s aggregation and propagation. We observed progressive aggregation of α-s in conventional neuronal cultures and in the exposed (proximal) compartments of circular tripartite networks following exposure to preformed α-s fibrils (PFF). Furthermore, aggregated forms propagated to distal compartments of the circular tripartite networks through axonal transport. We observed impacts of α-s aggregation on both the structure and function of neuronal cells, such as in presynaptic proteins, mitochondrial motility, calcium oscillations and neuronal activity. The model enabled an assessment of the early, middle, and late phases of α-s aggregation and its propagation during a 13-day follow-up period. While our temporal analysis suggested a complex interplay of structural and functional changes during the in vitro propagation of α-s aggregates, further investigation is required to elucidate the underlying mechanisms. Taken together, this study demonstrates the technical potential of our introduced model for conducting in-depth analyses for revealing such mechanisms.